真核起始因子4γ2通过下调Kv1.2和μ阿片受体参与小鼠神经病理性疼痛
该研究在小鼠脊髓神经结扎(SNL)模型中探究背根神经节(DRG)真核起始因子4γ2(eIF4G2)的作用。SNL后损伤侧DRG中eIF4G2 mRNA和蛋白水平呈时间依赖性升高;DRG内注射eIF4G2 siRNA可减轻SNL诱导的MOR和Kv1.2下调及痛觉过敏,而正常小鼠DRG过表达eIF4G2则降低MOR和Kv1.2并诱发痛觉过敏。结论:eIF4G2通过下调Kv1.2和MOR参与神经病理性疼痛。
要点
- SNL后损伤侧DRG中eIF4G2 mRNA和蛋白水平时间依赖性升高。
- 敲低损伤DRG的eIF4G2可减轻SNL诱导的MOR和Kv1.2下调及痛觉过敏。
- 正常小鼠DRG过表达eIF4G2降低MOR和Kv1.2并诱发痛觉过敏。
核心结论
- eIF4G2通过参与损伤DRG中Kv1.2和MOR的下调而促成神经病理性疼痛,是该病的潜在治疗靶点。
研究设计与样本
- 小鼠SNL模型,评估DRG中eIF4G2表达与分布,并通过DRG显微注射eIF4G2 siRNA或AAV5-eIF4G2观察功能效应。
主要发现
- eIF4G2蛋白与Kv1.2和MOR在DRG神经元中共表达。
- SNL后第3-14天损伤DRG中eIF4G2 mRNA升至假手术组的1.7(0.24)至2.3(0.14)倍(P<0.01)。
- SNL后第3-14天损伤DRG中eIF4G2蛋白升至假手术组的1.6(0.14)至2.5(0.22)倍(P<0.01)。
- 损伤DRG显微注射eIF4G2 siRNA减轻SNL诱导的DRG MOR和Kv1.2下调及痛觉过敏的发生与维持。
- 正常小鼠DRG显微注射AAV5-eIF4G2降低DRG MOR和Kv1.2表达并诱发对机械、热和冷刺激的痛觉过敏。
临床怎么用
- DRG eIF4G2可能作为神经病理性疼痛的潜在干预靶点,但尚需临床验证。
局限性
- 研究为小鼠SNL模型,结果向人类神经病理性疼痛的外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nerve injury-induced changes in gene expression in the dorsal root ganglion (DRG) contribute to neuropathic pain genesis. Eukaryotic initiation factor 4 gamma 2 (eIF4G2) is a general repressor of cap-dependent mRNA translation. Whether DRG eIF4G2 participates in nerve injury-induced alternations in gene expression and nociceptive hypersensitivity is unknown. METHODS: The expression and distribution of eIF4G2 mRNA and protein in mouse DRG after spinal nerve ligation (SNL) were assessed. Effects of eIF4G2 siRNA microinjected through a glass micropipette into the injured DRG on the SNL-induced DRG mu opioid receptor (MOR) and Kv1.2 downregulation and nociceptive hypersensitivity were examined. In addition, effects of DRG microinjection of adeno-associated virus 5-expressing eIF4G2 (AAV5-eIF4G2) on basal DRG MOR and Kv1.2 expression and nociceptive thresholds were analysed. RESULTS: eIF4G2 protein co-expressed with Kv1.2 and MOR in DRG neurones. Levels of eIF4G2 mRNA (1.7 [0.24] to 2.3 [0.14]-fold of sham, P<0.01) and protein (1.6 [0.14] to 2.5 [0.22]-fold of sham, P<0.01) in injured DRG were time-dependently increased on days 3-14 after SNL. Blocking increased eIF4G2 through microinjection of eIF4G2 siRNA into the injured DRG attenuated SNL-induced downregulation of DRG MOR and Kv1.2 and development and maintenance of nociceptive hypersensitivities. DRG microinjection of AAV5-eIF4G2 reduced DRG MOR and Kv1.2 expression and elicited hypersensitivities to mechanical, heat and cold stimuli in naïve mice. CONCLUSIONS: eIF4G2 contributes to neuropathic pain through participation in downregulation of Kv1.2 and MOR in injured DRG and is a potential target for treatment of this disorder.
引用
- Zhang Z, Zheng B, Du S, et al. Eukaryotic initiation factor 4 gamma 2 contributes to neuropathic pain through down-regulation of Kv1.2 and the mu opioid receptor in mouse primary sensory neurones. Br J Anaesth. 2020. PMID: 33303185. doi:10.1016/j.bja.2020.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。